Literature DB >> 4055543

Oral cefuroxime axetil: clinical pharmacology and comparative dose studies in urinary tract infection.

D H Adams, M J Wood, I D Farrell, C Fox, A P Ball.   

Abstract

Cefuroxime axetil, an orally absorbed pro-drug of cefuroxime was used to treat a mainly elderly group of patients with symptomatic urinary tract infections. The drug was clinically effective and the bacteriological short term and long term cure rates (55% and 48% respectively) comparable to those of other antibiotics. The study had to be terminated however after the development of three cases of antibiotic associated colitis. Studies of the pharmacokinetics of the drug in volunteers gave inconsistent results suggesting that there may be variable bioavailability of the compound.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4055543     DOI: 10.1093/jac/16.3.359

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  9 in total

1.  What is a suitable dissolution method for drug nanoparticles?

Authors:  Desmond Heng; David J Cutler; Hak-Kim Chan; Jimmy Yun; Judy A Raper
Journal:  Pharm Res       Date:  2008-03-05       Impact factor: 4.200

2.  In vitro and in vivo evaluations of a new broad-spectrum oral cephalosporin, BMY-28232, and its prodrug esters.

Authors:  K Tomatsu; S Masuyoshi; M Hirano; H Kawaguchi; T Oki; J Fung-Tomc; J V Desiderio; R E Kessler
Journal:  Antimicrob Agents Chemother       Date:  1989-04       Impact factor: 5.191

Review 3.  The future of new oral antibiotics including the quinolones.

Authors:  M G Bergeron
Journal:  CMAJ       Date:  1988-01-01       Impact factor: 8.262

4.  Comparative trial of cefuroxime axetil in recurrent urinary tract infections illustrating importance of 6-week follow-up.

Authors:  W Brumfitt; J M Hamilton-Miller; G W Smith
Journal:  Antimicrob Agents Chemother       Date:  1987-09       Impact factor: 5.191

5.  Preparation and evaluation of cefuroxime axetil gastro-retentive floating drug delivery system via hot melt extrusion technology.

Authors:  Rahul Lalge; Priyanka Thipsay; Vijay Kumar Shankar; Abhijeet Maurya; Manjeet Pimparade; Suresh Bandari; Feng Zhang; S Narasimha Murthy; Michael A Repka
Journal:  Int J Pharm       Date:  2019-06-08       Impact factor: 5.875

Review 6.  Cephalosporins in urinary tract infection.

Authors:  L O Gentry
Journal:  Drugs       Date:  1987       Impact factor: 9.546

7.  Cefuroxime axetil in acute purulent exacerbations of chronic bronchitis.

Authors:  B I Davies; F P Maesen; J P Teengs
Journal:  Infection       Date:  1987 Jul-Aug       Impact factor: 3.553

8.  Intragastric floating drug delivery system of cefuroxime axetil: In vitro evaluation.

Authors:  Viral F Patel; Natavarlal M Patel
Journal:  AAPS PharmSciTech       Date:  2017-03-08       Impact factor: 3.246

Review 9.  Cefuroxime axetil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  C M Perry; R N Brogden
Journal:  Drugs       Date:  1996-07       Impact factor: 9.546

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.